Article
Single-cell multiplex approaches deeply map ON-target CRISPR-genotoxicity and reveal its mitigation by palbociclib and long-term engraftment.
Nature communications - 10 Jan 2026
Boutin Julian, Fayet Sabrina, Marin Victor, Bergès Camille, Riandière Maude, Toutain Jérôme, Lamrissi-Garcia Isabelle, Thibault Chloé, Cappellen David, Dabernat Sandrine, Poulet Arthur, Francillette Maëla, Droin Nathalie, Debeissat Christelle, Brunet de la Grange Philippe, Moreau-Gaudry François, Bedel Aurélie
Abstract excerpt
Genome editing by CRISPR-Cas9-nuclease is promising for gene therapy. However, safety concerns remain. Monitoring ON-target genotoxicity is essential, especially to assay megabasic rearrangements at the targeted locus. Here, we developed a combined single-cell resolution approach with DNA sequencing focused on single nucleotide polymorphism (scSNP-DNAseq), micronuclei and LOH cytometry-reporter assays. This...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
